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Abstract 
Background/Objective: We aimed to describe serum 25-hydroxyvitamin D (25OHD) 
concentrations in older Europeans and to investigate associations between 25OHD and 
lifestyle factors, including dietary intake and supplement use.  
Subjects/Methods: Men and women aged ≥65 years were recruited from seven centres across 
north to south Europe. Serum 25OHD2 and 25OHD3 concentrations were measured by liquid 
chromatography tandem mass spectrometry (LC-MS/MS) in 4495 samples and total 25OHD 
(25OHD2 + 25OHD3) was adjusted for season of blood collection.  
Results: The mean (25th, 75th quartile) of seasonally adjusted 25OHD was 46 (34, 65) 
nmol/L, with the highest concentration of 25OHD in Bergen [61 (49, 79) nmol/L], and the 
lowest in Paris [36 (24, 57) nmol/L)]. Vitamin D deficiency (25-50 nmol/L) and vitamin D 
insufficiency (50-75 nmol/L) were found in 41% and 33% of the population, respectively. In 
multivariable analysis controlled for confounders, seasonally adjusted 25OHD concentrations 
were significantly (p<0.05) lower in smokers and participants with self-reported diabetes and 
higher with increasing dietary vitamin D, and supplement use with fish liver oil, omega-3 and 
vitamin D. Additionally in further analysis excluding Bergen, 25OHD was associated with 
higher intakes of oily fish and increasing UVB exposure. We observed low concentrations of 
25OHD in older people in Europe.  
Conclusions: Our findings of the higher 25OHD concentrations in supplement users (omega-
3 fish oil, fish liver oil, vitamin D) add to current recommendations to reduce vitamin D 
deficiency. We were unable to fully assess the role of dietary vitamin D as we lacked 
information on vitamin D fortified foods.   
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Introduction 
Vitamin D deficiency (<50 nmol/L) is highly prevalent in older people (1–4). Serum 25-
hydroxyvitamin D (25OHD) concentrations in Central Europe can vary from 32.5 to 72.5 
nmol/L, with seasonal variability present (5). The main source of vitamin D is the 
endogenous production of vitamin D3 from sunlight (6). However, seasonal and latitudinal 
effects in Europe can reduce the production of vitamin D3 from the sun (7–10). The main 
sources of dietary vitamin D are oily fish and eggs (11,12), however, eggs despite being 
considered an important source of vitamin D, have a relatively low dietary vitamin D content. 
There is also evidence to suggest meat may be a vital source of dietary vitamin D (13). Social 
isolation and reduced mobility, both of which can lead to a decrease in the time spent 
outdoors, has been suggested as a reason for lower concentrations of total 25OHD (Total 
25OHD= 25OHD2 + 25OHD3) in older individuals (14). Effective dietary strategies, 
including supplements, have been recommended by a number of research organisations and 
research groups for an older population group (15–17). 40-100 micrograms of supplement 
vitamin D has been suggested in addition to safe UVB exposure. This particular group have 
suggested vitamin D deficiency be defined as <50 nmol/L, 50-75 nmol/L as suboptimal and 
75-125 nmol/L as optimal vitamin D concentration (18). It has also been suggested that target 
vitamin D concentrations and recommended vitamin D supplement values should be age-, 
body weight-, disease status- and ethnicity-dependent rather than focused on age alone. In 
addition, the recommendations should also depend on one's individual health outcome 
concerns, latitude of residence, dietary and cultural habits. This would ensure 
national/international guidelines would be more applicable to clinical practices (19).  
There is a large amount of variability in the literature regarding 25OHD concentrations in 
different countries(20–23). The use of different assays and discrepancies over the definition 
of vitamin D deficiency makes the comparison of literature from various countries and in 
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different population groups difficult. A recent paper by Cashman and colleagues tried to 
address this issue by applying vitamin D standardization program (VDSP) protocols to 
existing 25OHD data from 55844 participants from representative studies for European 
children, teenagers, adults and older adults. The authors concluded that vitamin D deficiency 
(defined as <30 nmol/L) was highly prevalent in Europe, with 13% of individuals being 
deficient throughout the year. Deficiency throughout the winter months (November to March) 
was 18%, and 8% in the summer months (April-October)(21).  
The European Eye (EUREYE) study was a cross-sectional study of older people from centres 
in seven countries spanning north to south Europe, originally set up to investigate risk factors 
for age-related macular degeneration. In previous analyses we reported the association 
between vitamin D deficiency and age-related macular degeneration (24) and total 25OHD 
concentrations and myopia (25) .In the present analysis, we aimed to further describe 25OHD 
concentrations, including prevalence of vitamin D deficiency, and to investigate the 
association of key demographic, clinical and lifestyle factors, including dietary factors, with 
25OHD concentrations.   
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Research materials and methods 
The methods for the EUREYE study have been published in detail elsewhere (26). Briefly, 
participants were recruited during 2001 and 2002 by random sampling of the population aged 
65 years and older in seven centres: Bergen, Norway; Tallinn, Estonia; Belfast, Northern 
Ireland; Paris, France; Verona, Italy; Thessaloniki, Greece; and Alicante, Spain. Over 11000 
people were invited, of whom 5040 participated (45% response rate) (27). The response rate 
ranged from 35% (Verona) to 59% (Tallinn), in men (50%) compared to women (42%) and 
in the age group 65-74 (48%) compared to those 75 years and over (39%). Written informed 
consent was obtained from all study participants. Ethical approval was obtained for each 
centre from the relevant ethics committee and the research adhered to the tenets of the 
Declaration of Helsinki. 
Participants were interviewed at the research clinic in each centre on a one to one basis by 
trained fieldworkers using a structured questionnaire. Information including age, smoking, 
alcohol use, previous cardiovascular events (angina, stroke, and heart attack) or history of 
diabetes mellitus, diet and sunlight exposure was obtained. Details of the diet (28) and 
sunlight questionnaires (29) have been described elsewhere and are summarised briefly here.  
The UK European Prospective Investigation into Cancer and Nutrition (EPIC) study food 
frequency questionnaire (FFQ) (30) was used and modified in non-UK centres to include 
additional food items or local varieties of a food item. The intake of oily and white fish was 
asked about separately. Information on supplement use was recorded. Quantification of 
dietary intake of vitamin D was based on food sources alone, as the FFQ was not designed to 
facilitate the quantification of vitamin D intake from the diet via food fortification. Nutrient 
intake including vitamin D was estimated using the food-composition tables from the 5th 
edition of McCance and Widdowson’s “The Composition of Foods” (31). Dietary vitamin D 
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was adjusted for total energy intake using the residual model (32). We used a sunlight 
questionnaire to ask about place of residence and time spent outdoors between the hours of 9 
a.m. and 5 p.m. and between 11 a.m. and 3 p.m daily. Estimates of exposure for different 
wavelengths of light (UVA, UVB and blue light) were generated from questionnaire data 
along with estimates from published sources that take into account time of day, month, and 
latitudinal variations modified by cloud cover and terrain. In these analyses we used middle 
of the day estimates for UVB as this is the period when sun exposure is at its highest.  
At the clinical exam, systolic and diastolic blood pressure, weight and demispan were 
measured and a non-fasting blood sample collected from each participant. Blood samples 
were separated within 4 hours of collection and serum stored at -20º C for up to 4 weeks 
before being transferred to a single laboratory (Queens University Belfast) for storage at -80º 
C.  
The full procedure for the measurement of 25OHD2/25OHD3 has been published elsewhere 
(33). Briefly, serum samples were prepared using a liquid-liquid extraction technique. 
Working standards and quality control samples were prepared by diluting commercially 
available 25OHD2 and 25OHD3 bi-level serum controls (Chromsystems, Munchen, 
Germany) into horse serum (Sigma- Aldrich Co Ltd, Poole, UK). A d6-25OHD3 internal 
standard was used in both standards and serum samples. Samples were analysed for 25OHD2 
and 25OHD3 by liquid chromatography tandem mass spectrometry (LC-MS/MS) [Waters® 
Xevo TQ-S® & ACQUITY UPLC (Waters Corporation, Milford, MA, USA)]. The intra-
assay precision ranged from 1.6-3.6% and 1.1-4.0% for 25OHD2 and 25OHD3, respectively. 
The inter-assay precision ranged from 1.2-5.7% and 1.2-3.0% for 25OHD2 and 25OHD3, 
respectively. These measurements took place on the stored samples some 8 to 10 years after 
initial collection.  
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Statistical analysis 
Statistical analysis was carried out using STATA 14 (StataCorp, College Station, TX, USA.). 
Normal distribution of variables was tested using normality plots and, subsequently, dietary 
vitamin D and total 25OHD (25OHD2 + 25OHD3) were logarithmically transformed. Season 
was defined by the date of blood collection as winter (December, January, February), spring 
(March, April, May), summer (June, July, August) and autumn, (September, October, 
November). Season was accounted for using sine wave analysis using the month of blood 
collection. Analysis using 25OHD was seasonally adjusted where required. Serum 25OHD 
was defined as grossly deficient (<25 nmol/L), deficient (25-50 nmol/L) and insufficient 
(50.75 nmol/L) as per published guidelines (16).  
Seasonally adjusted total 25OHD concentrations were compared between two categories 
using an independent samples t test. For more than two categories, ANOVA was used. 
Categorical variables were compared using chi-square analysis. Variables were entered into 
multivariate analysis if their p-value was less than 0.05 in the univariate analysis. Multiple 
linear regressions were used to determine factors which were independently associated with 
25OHD by adding the variables into a general linear model. Beta coefficients and 95% 
confidence intervals (CI) in the multivariable analysis are reported. 
Study design (7 centres) was accounted for by using the STATA survey command in the 
estimation of means, corresponding p values and 95% CI. Design-adjusted Pearson chi-
square tests were used for comparing categorical variables with categorical variables and 
design-adjusted Wald tests were used for comparing continuous variables with categorical 
variables.  
As 25OHD and dietary vitamin D were log-transformed, mean and 95% CI were presented as 
geometric mean and 25th-75th quartiles. Pearson correlation coefficients and the multiple 
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regression coefficients which used a logged variable as a dependent variable were back 
transformed.   
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Results 
Blood samples were available for 4704 participants (93.4%), of who 191 had no information 
on date of blood collection. A further 18 participants with total 25OHD concentrations 
greater than 150 nmol/L (11 due to implausibly high 25OHD2 values) were excluded, leaving 
a final sample of 4495 available for analysis.  
Demographic and lifestyle characteristics of study participants are presented in Table 1. The 
mean age was similar across the seven centres (71 to 74 years). UVB exposure was lower in 
north European centres compared to southern European centres. Paris had the lowest UVB 
exposure and Thessaloniki the highest. The BMI of participants in the normal (18.5-25.0 
kg/m2), overweight (>25.0 kg/m2), and obese (>30.0 kg/m2) categories varied across the 
centres. Prevalence of obesity ranged from 19.8% in participants from Belfast to 51.0% in 
Thessaloniki. Similarly, the prevalence of self-reported diabetes was highest in Thessaloniki 
(23.4%). Current smoking status varied among the centres, Paris had the lowest percentage of 
smokers (8.2%), with Thessaloniki and Bergen having twice as many (18.3 and 18.1%, 
respectively) compared to Paris. The use of fish liver oil or, omega-3 fish oil and vitamin D 
supplements varied across the centres: Bergen had the highest number of omega-3 
supplement users (43.7%), and Belfast for fish liver oil (24.3%). The remaining centres had 
extremely low intakes of fish liver oil or omega-3 supplement use, for example, Alicante had 
no supplement users. Vitamin D supplement use was low in the seven study centres, with 
Bergen having the highest percentage of supplement users (3.9%), and Thessaloniki having 
no users of vitamin D supplements.  
Figure 1 shows the comparison of 25OHD concentrations by season overall and by centre. 
Overall, participants whose blood were collected between December and May had 
significantly lower 25OHD concentrations compared to those collected between June and 
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November (41 and 51 nmol/L, respectively p<0.001). Seasonal differences were observed 
between each centre (p<0.001), with the exception of Bergen (p=0.55).  
Table 2 shows the seasonally adjusted geometric mean and 25th, 75th quartiles for 25OHD, 
prevalence of participants who were grossly deficient (<25 nmol/L), deficient (25-50 nmol/L) 
and insufficient (50-75 nmol/L) in 25OHD and dietary vitamin D intake by centre. Bergen 
had significantly higher 25OHD concentrations than all other centres (61 nmol/L), while the 
lowest 25OHD concentration was found in Paris (36 nmol/L). The proportion of vitamin D 
deficiency was 41% overall, and varied by centre with the lowest proportion in Bergen 
(26%), and the highest in Thessaloniki (48%). The proportion with insufficient vitamin D 
concentrations was 33% overall, lowest in Paris (21%) and highest in Bergen (44%). Dietary 
vitamin D intake varied by centre, with a two-fold difference from the lowest dietary intake 
of vitamin D observed to the highest. Thessaloniki had the lowest intake of dietary vitamin D 
(1.2 µg/day), whereas the highest intake of dietary vitamin D was found in Alicante (2.9 
µg/day).  
In univariable analysis, factors associated with seasonally adjusted 25OHD concentrations 
were age, sex, alcohol consumption, self-reported diabetes, oily fish intake, dietary vitamin 
D, supplements with fish liver oil, omega-3, and vitamin D (Table 3). In multivariable 
analysis, increasing age, self-reported diabetes and current smoking were associated with 
lower 25OHD concentrations and increasing dietary vitamin D, and supplement use with fish 
liver, omega-3 or vitamin D with higher concentrations of 25OHD (Table 4). Supplement use 
especially omega-3 was associated with the largest differences in 25OHD between users and 
non-users. There was no evidence of collinearity in the analyses between different types of 
supplements. The model explained 10.8% of the variance in 25OHD concentrations. Because 
of the much higher concentrations of 25OHD in Bergen, we carried out a further analysis 
excluding participants from Bergen and dropping omega-3 and vitamin D supplement use 
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(since few participants outside the Bergen centre used these supplements).  In this model, 
age, diabetes and smoking remained significantly associated with lower 25OHD 
concentrations and, in addition to fish liver oil supplement, oily fish consumption >2 
portions/week and UVB exposure were associated with higher 25OHD concentrations (Table 
4). Results for dietary vitamin D were slightly attenuated compared to the previous model 
including Bergen. This model explained 7.2% of the variance in 25OHD concentrations. 
Differences in 25OHD were similar to those reported in the previous model including 
Bergen, for example around 5 nmol/L lower in participants with diabetes compared to 
participants with no reported diabetes in both models and 9 nmol/L higher with fish oil 
supplement use.  
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Discussion 
Our study confirms findings from studies of European populations of low 25OHD 
concentrations and high proportions with vitamin D deficiency or insufficient levels (21). We 
observed that for serum 25OHD concentrations there was no north to south gradient, as 
would perhaps have been expected for vitamin D. Lower concentrations of vitamin D were 
expected in more northerly centres due to reduced UVB exposure during the year compared 
to more southern countries. Bergen despite its geographical location as one of the most 
northerly located had the highest level of 25OHD and the lowest prevalence of vitamin D 
deficiency. This finding has also been observed in other observational studies and systematic 
reviews (20,21,34,35). Hilger and colleagues investigated global 25OHD concentrations in 
several countries and age groups in a systematic review. While global 25OHD concentrations 
were approximately 53 nmol/L, it was observed in sub-analysis that older people in Sweden 
had comparatively higher 25OHD concentrations than any other older population in Europe 
(20). It can be hypothesised that Sweden and Norway would have similar dietary and cultural 
practices in addition to similar UVB exposure. Cashman and colleagues reported, based on 
14 European population-based studies, that, in both adults and older adults, the prevalence of 
vitamin D deficiency was lower in more northerly latitude countries, such as Norway, 
Finland and Iceland, whereas countries in central Europe had a higher prevalence of vitamin 
D deficiency (21). It has been hypothesised that the high levels of 25OHD observed in 
Norway may be due to the high consumption of fish and food fortification of basic food items 
(34,35). Comparable to the current study, O’Neill and colleagues observed higher 25OHD 
concentrations in northern European countries, compared to central Europe during the winter 
months (36). The high proportion of omega-3 fish oil supplement users in Bergen (44%) is 
likely to be one of the sources of the high 25OHD concentrations. It is also notable that fish 
oil ,which is the likely source of vitamin D in the Norwegian population, is considered a food 
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rather than a supplement (37). Omega-3 fish oils were strongly associated with seasonally 
adjusted 25OHD despite these supplements not containing vitamin D. We hypothesise but 
cannot confirm that the omega-3 fish oils consumed by participants in Bergen could be 
fortified with vitamin D. The use of omega-3 fish oil supplements was low in all other centres 
in the current study; in contrast fish liver oil supplement was more common in Belfast (24%). 
However the participants in the Bergen sample may have other characteristics that are 
associated with increased production of 25OHD3 concentrations through UVB exposure such 
as paler skin (38). In contrast, Paris with the lowest 25OHD concentrations and the highest 
proportion of vitamin D deficiency had the lowest UVB exposures probably reflecting the 
lifestyle of a central urban population.  
Age was negatively associated with 25OHD concentrations. Ageing can have a substantial 
effect on 25OHD concentrations. This is predominantly due to the reduced dermal capacity of 
older indivduals to produce vitamin D3. The capacity of the skin to produce vitamin D3 is 
approximately 75% less in an older indivdual (>65 years) compared to an average 25 year old 
being exposed to the same amount of UVB radiation (39,40). Decreasing concentrations of 
25OHD with increasing age may also be due to a change in behaviours, for example, older 
individuals tend to be outside less due to decreased ability to do physical activity and may 
wear more concealed clothing compared to their younger counterparts (41).Van Schoor and 
colleagues observed in a younger cohort (average age 60 ±3.0 years; n=738) that, for every 
year increase, 25OHD increased by 0.6 nmol/L, whereas in the older cohort (average age 76.0 
±6.7 years; n=1320), it was observed that for every year increase in age, 25OHD decreased 
by 1.0 nmol/L(42). 
Smoking was negatively associated with serum 25OHD in the current study. This is in line 
with a study from a Danish population of 510 perimenopausal women aged 45-58 years. 50% 
of study participants were current smokers, and it was observed that smoking significantly 
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decreased serum 25OHD (43). Additionally, in a study of 612 older men of which 31% were 
current smokers, current smokers had significantly lower vitamin D than those who never 
smoked. This association showed a dose-response relationship (44). The method by which 
smoking influences serum 25OHD is currently unknown, and difficult to determine due to the 
large number of toxic chemical compounds. There is evidence to suggest that smokers have 
altered hepatic function (45), and therefore could influence 25OHD concentrations.  
Dietary vitamin D intake in the current study was below the recommended adequate intake 
(AI) for European adults as set by the European Food Safety Authority (EFSA) (46). EFSA 
suggests that the AI for adults (>18 years of age) should be 15 µg/day. The highest observed 
intake of dietary vitamin D in the current study was in Alicante (2.9 µg /day), and the overall 
average for the total population was 2.0 µg/day. In contrast, the European Prospective 
Investigation into Cancer and Nutrition (EPIC) study observed a north/south gradient for 
dietary vitamin D intakes. The highest dietary vitamin D intake was observed in Sweden (7.6 
µg/day), with the lowest observed in Italy (1.9 µg/day). Overall, the average dietary vitamin 
D intake across Europe in the EPIC study was 4.2 µg/day (47). While these intakes are still 
below the AI for European adults, they are higher than observed in the current study. This 
may be due to the inability of our dietary analysis to quantify dietary vitamin D from fortified 
foods. Fortified foods are an important source of dietary vitamin D in several countries. 
Mandatory fortification with vitamin D of margarine, butter and one type of skimmed milk is 
employed in Norway(48). Up until 2013 the UK had mandatory fortification of margarine 
with vitamin D, the current study was conducted between 2001-2002, and therefore 
margarine was subject to fortification. Voluntary fortification is also in use in the UK and 
France for food items such as dairy foods, cereals and vegetable oils (17,49). The remaining 
centres (Estonia, Italy, Spain and Greece) have no formal fortification practices (23,50,51). 
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This could suggest that our study has been unable to identify important sources of dietary 
vitamin D in habitual diets in several centres.  
Lower serum 25OHD concentrations were associated with self-reported diabetes in the 
current study. Only a few studies have investigated the relationship between 25OHD and 
diabetes in an older population. Hirani and colleagues found that in people (>70 years) 
25OHD concentrations of less than 50 nmol/L were associated with type 2 diabetes in 
confounder adjusted analysis (OR = 1.73, 95% CI = 1.04–2.86, p=0.03). 25OHD 
concentrations above 50 nmol/L were not significantly associated with type 2 diabetes(52). 
Park and colleagues in a 12 year longitudinal study of older people observed higher 25OHD 
concentrations (>75 nmol/L) had a lower hazard ratio for type 2 diabetes compared to lower 
25OHD concentrations. There was an inverse dose-response gradient between 25OHD 
concentration and risk of diabetes; each 25 nmol/L increase was associated with a 0.64 
hazard ratio for diabetes (53). These findings of an association between lower 25OHD and 
diabetes in an older population have important implications for health. Type 2 diabetes is a 
growing health problem (54) and, if compounded by deficiency of vitamin D, which has 
important roles in bone health and immune regulation (55,56), may potentially cause worse 
morbidity in this group. The association of 25OHD with type 2 diabetes is biologically 
plausible, as it has been suggested that vitamin D sufficiency may be required for optimal 
insulin action and secretion, which are two fundamental features of type 2 diabetes. The 
vitamin D receptor and 1-α-hydroxylase are both present in β-cells of the pancreas (57,58). 
In-vitro and in-vivo studies show that vitamin D receptor knockout mice, had impaired 
glucose induced insulin secretion, and the insulin secretory response only improved after 
vitamin D supplementation in both animals and humans. However, a causal effect remains to 
be demonstrated in human studies and cannot be determined from this class of a study(59). 
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The current study has several strengths and limitations. We investigated data from seven 
centres that spanned latitudes extending from north to south of Europe, and this encompassed 
a range of dietary habits and lifestyle behaviours. 25OHD2 and 25OHD3 were measured using 
the gold-standard method of measuring 25OHD (LC-MS/MS) using commercial calibrators 
and internal standards. Accuracy and precision of the assay was also maintained using the 
vitamin D external quality assurance system (DEQAS). The limitations of the current study 
include the retrospective and self-reported nature of lifestyle variables, including supplement 
use, smoking, alcohol, diabetes and CVD history. EUREYE had a 45% response rate and this 
may have resulted in a sample that were more health conscious and therefore we may be 
underestimating the prevalence of vitamin D deficiency. The use of UK food tables to 
analyse the dietary intake of all centres is a limitation, since country-specific food tables were 
not available for the majority of the countries involved in the EUREYE study. Furthermore, 
information on vitamin D supplement use was relatively limited, with only vitamin D 
supplement intake being included if reported; multivitamin use that may have included 
vitamin D was not included use due to a lack of individual level data on the brands of 
supplements. Information on ethnicity and skin colour of the participants were also not 
available in the current study. As this is a cross-sectional observational study, we cannot 
conclude any casual or confirmatory effects of low 25OHD concentrations on type 2 diabetes.   
In conclusion, we observed low concentrations of 25OHD across Europe in an older 
population group, an overall vitamin D deficiency of 41% and noted the lack of a north-south 
gradient. Our findings of the higher 25OHD concentrations in supplement users (omega -3 
fish oil, fish liver oil, vitamin D) confirm those reported in other European studies (21) and 
support recommendations in the UK (17) and other European countries (35) for improving 
25OHD concentrations. We were unable to fully assess the role of dietary vitamin D as we 
lacked information on vitamin D fortified foods.  
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Fig. 1 Comparison of total 25OHD concentrations between seasons in the EUREYE 1 
population and by centre 2 
25OHD, 25-hydroxyvitamin D, nmol/L, nanomole per litre 3 
Results are presented as geometric mean and 25th,75th quartiles 4 
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